US Patent 7351567 Enzymatic resolution of selective estrogen receptor modulators
Patent 7351567 was granted and assigned to Pfizer on April, 2008 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+168 characters)
Article
Patent abstract
The present invention relates to a process for preparing 5-substitued-6-cyclic-5,6,7,8-tetrahydronaphthalen-2-ol compounds useful as an estrogen agonist.
Edits on 26 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 20 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07351567 Enzymatic resolution of selective estrogen receptor modulators US Patent 7351567 Enzymatic resolution of selective estrogen receptor modulators
Infobox
Patent Number
0735156700
Patent Number
735156700
Edits on 27 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073515670
Date of Patent
April 1, 2008
0Patent Application Number
107914620
Date Filed
March 2, 2004
0Official Website
Patent Primary Examiner
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073515670
Date of Patent
April 1, 2008
0Patent Application Number
107914620
Date Filed
March 2, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 24 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07351567 Enzymatic resolution of selective estrogen receptor modulators
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07351567
Date of patent
April 1, 2008
Patent application number
10791462
Date Filed
March 2, 2004
Patent primary examiner
Find more entities like US Patent 7351567 Enzymatic resolution of selective estrogen receptor modulators
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
